HLB Group Files Shareholding Report for Management Influence, Enters Call Option Contracts on Convertible Bonds

Filed substantial shareholding report for the purpose of influencing management (issuer not specified, targets HLB group affiliates)
HLB and HLB Pharma entered into call option contracts on convertible bonds with multiple securities firms
HLB call option face value: approx. KRW 6.48 billion (BNK, KB Securities, Mirae Asset, NH Securities, Samsung Securities, Shinhan Investment, Cloud IB Investment)
HLB Pharma call option face value: approx. KRW 3.24 billion (same counterparties)
Reporting purpose: to influence management (general form)
Detailed changes in shareholding not disclosed